Stockreport

Syndax (SNDX) Gets FDA Priority Tag for Leukemia Drug NDA [Yahoo! Finance]

Syndax Pharmaceuticals, Inc.  (SNDX) 
Last syndax pharmaceuticals, inc. earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.syndax.com
PDF The NDA seeks approval of revumenib, a first-in-class menin inhibitor, for the treatment of patients with relapsed/refractory acute leukemia harboring a KMT2A rearrangem [Read more]